Tore Viana-Rønningen (CEO) has today received proxies to represent and vote for 2,329,782 shares at the extraordinary general meeting in CellCura ASA to be held 21 November 2014. The received proxies represent approximately 35.73 per cent of the share capital.

Tore Viana-Rønningen does not own any shares in CellCura ASA. Viana-Rønningen will hence represent 2,329,782 shares and voting rights at the general meeting, corresponding to approximately 35.73 per cent of the share capital in CellCura ASA. The proxies are only valid at the above mentioned general meeting.

Oslo, 21 November 2014

CellCura ASA
Tore Viana-Rønningen
Chief Executive Officer
Telefon: +47 911 08 693

CellCura ASA is dedicated to the development and sales of cell technologies for use in assisted reproductive technology (ART) and stem cell research worldwide, representing improved safety and efficiency compared to traditional technology. CellCura is listed on the Oslo Axess market at the Oslo Stock Exchange (ticker: CELL).

www.cellcura.com

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

distributed by